Banque Internationale à Luxembourg S.A. Share Price

Certificat

ATYBIL

CH1244707480

Market Closed - Swiss Exchange 08:50:00 28/06/2024 pm IST
90.85 EUR -0.20% Intraday chart for Banque Internationale à Luxembourg S.A.
Current month-0.98%
1 month-2.04%
Date Price Change
28/24/28 90.85 -0.20%
27/24/27 91.03 -0.84%
25/24/25 91.8 +0.25%
24/24/24 91.57 +1.55%
21/24/21 90.17 +0.12%

Delayed Quote Swiss Exchange

Last update June 28, 2024 at 08:50 pm IST

More quotes

Static data

Product typesonstige Zertifikate
Buy / SellCALL
Underlying SANOFI
Issuer Banque Internationale à Luxembourg S.A.
ATYBIL
ISINCH1244707480
Date issued 05/05/2023
Maturity 05/05/2028 (1406 Days)
Parity 0.1 : 1
Emission price 100
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 100.5
Lowest since issue 82.58
Spread 8
Spread %0.88%

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
89.94 EUR
Average target price
107.9 EUR
Spread / Average Target
+19.93%
Consensus
  1. Stock Market
  2. Certificates
  3. ATYBIL Certificat